RECITALSInvestor Rights Agreement • October 28th, 2003 • Advanced Biotherapy Inc • Services-commercial physical & biological research • California
RECITALSInvestor Rights Agreement • May 15th, 2002 • Advanced Biotherapy Inc • Services-commercial physical & biological research • California
EXHIBIT 10 THIS COMMON STOCK PURCHASE WARRANT (THE "WARRANT") AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THE WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE SECURITIES LAW OF ANY JURISDICTION. NEITHER...Common Stock Purchase Warrant • May 15th, 2000 • Advanced Biotherapy Concepts Inc • Services-commercial physical & biological research • Nevada
RECITALSInvestor Rights Agreement • August 13th, 2002 • Advanced Biotherapy Inc • Services-commercial physical & biological research • California
AMENDMENT NO. 1 TO SECURITY AGREEMENTSecurity Agreement • November 4th, 2008 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Illinois
This Amendment No.1 to Security Agreement (this “Amendment”) is made as of October 31, 2008, by and among Lime Energy Co., a Delaware corporation (the “Debtor”), and Richard P. Kiphart (“Kiphart”) and Advanced Biotherapy, Inc. (“ADVB” and together with Kiphart, the “Secured Parties,” and each, a “Secured Party”), and amends the Security Agreement dated as of August 14, 2008 (“Existing Agreement”) by and among the Debtor and the Secured Parties.
REIMBURSEMENT AGREEMENTReimbursement Agreement • December 21st, 2007 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Delaware
This Reimbursement Agreement (“Agreement”), dated as of December 18, 2007, is by and between Organic Farm Marketing, LLC (“Company”), a Wisconsin limited liability company, and Advanced Biotherapy, Inc. (“Investor”), a Delaware corporation.
RECITALSInvestor Rights Agreement • August 12th, 2005 • Advanced Biotherapy Inc • Services-commercial physical & biological research • California
AR NOTE ISSUANCE AGREEMENTAr Note Issuance Agreement • June 13th, 2008 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Illinois
This AR Note Issuance Agreement (this “Agreement”) is dated as of the 6th day of June, 2008, and is made by and between Lime Energy Co., a Delaware corporation (the “Company”), and Richard P. Kiphart (“Kiphart”) and Advanced Biotherapy, Inc. (“ADVB” and together with Kiphart, “Noteholders”).
ContractInvestment Agreement • December 21st, 2007 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Delaware
This Investment Agreement (“Agreement”) dated as of December 18, 2007, is between ADVANCED BIOTHERAPY, INC., a Delaware corporation (“Investor”), and ORGANIC FARM MARKETING, LLC, a Wisconsin limited liability company (the “Company”).
Pledge Agreement (Deposit Account) Dated December 14, 2007Pledge Agreement • December 21st, 2007 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Illinois
This Pledge Agreement (“this Agreement”) has been executed by Advanced Biotherapy, Inc., a corporation organized under the law of the State of Delaware, as debtor (“we,” “us,” “our” or “Debtor”) in favor of The Northern Trust Company (“you,” “your” or "Secured Party"). For good and valuable consideration, the receipt and adequacy of which are acknowledged Debtor agrees as follows:
Exhibit 10.13 AGREEMENT FOR JOINT CLINICAL INVESTIGATIONS Both sides note that the first treatment of autoimmune diseases by removal of interferons (cytokines) was proposed in 1974 by Professor S.V. Skurkovich (Nature, 1974;247:551-2). He also...Joint Clinical Investigations Agreement • August 4th, 2003 • Advanced Biotherapy Inc • Services-commercial physical & biological research
Both sides note that the first treatment of autoimmune diseases by removal of interferons (cytokines) was proposed in 1974 by Professor S.V. Skurkovich (Nature, 1974;247:551-2). He also proposed to remove TNF-(alpha) in various autoimmune conditions, including AIDS (J IFN & Cytokine Res 1989;9:S2 and other publications and patents). The use of anticytokines in autoimmune conditions has received wide experimental and clinical confirmation in various laboratories of the world. As is known, organ transplant rejection is also connected with autoimmune mechanisms. In joint investigations positive results were obtained with the use of antibodies to interferon-(gamma) in corneal transplants (Treatment of corneal transplant rejection in humans with anti-interferon-(gamma) antibodies,. Am J Opthalmol 2002;133:829-30).
AMENDED AND RESTATED NOTE ISSUANCE AGREEMENTNote Issuance Agreement • November 4th, 2008 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Illinois
This Amended and Restated Note Issuance Agreement (this “Agreement”) is dated as of the 31st day of October, 2008, and is made by and between Lime Energy Co., a Delaware corporation (the “Company”), Richard P. Kiphart (“Kiphart”) and Advanced Biotherapy, Inc. (“ADVB” and together with Kiphart, “Noteholders”).
NOTE ISSUANCE AGREEMENTNote Issuance Agreement • March 14th, 2008 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Illinois
This Note Issuance Agreement (this “Agreement”) is dated as of the 12th day of March, 2008, and is made by and between Lime Energy Co., a Delaware corporation (the “Company”), and Richard P. Kiphart (“Kiphart”) and Advanced Biotherapy, Inc. (“ADVB” and together with Kiphart, “Noteholders”).
SUBSCRIPTION AGREEMENT December 18, 2007 Advanced Biotherapy, Inc.Subscription Agreement • December 21st, 2007 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Delaware
GENERAL BUSINESS SECURITY AGREEMENTGeneral Business Security Agreement • December 21st, 2007 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Wisconsin
In consideration of any financial accommodation at any time granted by Advanced Biotherapy, Inc., a Delaware corporation (“Lender”), to Organic Farm Marketing, LLC, a Wisconsin limited liability company (“Debtor”), Debtor hereby grants Lender a security interest in all equipment, fixtures, inventory, documents, general intangibles, accounts, deposit accounts, contract rights, chattel paper, patents, trademarks and copyrights (and the good will associated with and registrations and licenses of any of them), instruments, letter of credit rights and investment property, now owned or hereafter acquired by Debtor, and all additions and accessions to, all spare and repair parts, special tools, equipment and replacements for software used in, all returned or repossessed goods, together with all proceeds, supporting obligations and products of the foregoing (“Collateral”), wherever located, to secure all debts, obligations and liabilities to Lender arising out of credit previously granted, cre
INTERCREDITOR AGREEMENTIntercreditor Agreement • December 21st, 2007 • Advanced Biotherapy Inc • Services-commercial physical & biological research • Delaware
This Intercreditor Agreement (“Agreement”) is entered into as of December 18, 2007, by and among Richard P. Kiphart, an individual (“Kiphart”), Advanced Biotherapy, Inc., a Delaware corporation (“Advanced”) and Organic Farm Marketing, LLC, a Wisconsin limited liability company (“Company”). This Agreement is made with respect to the following facts:
